secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2021-10-21T23:59:59+00:00
Accession:  0001628280-21-020321
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology annual meeting results: all proposals approved by shareholders
--------------------------------------------------------------------------------

- All seven director nominees elected; Scott R. Tobin received highest support (8,518,378 votes).
- EisnerAmper LLP ratified as independent auditor for FY2022 (8,762,596 for, 326 against).
- Non-binding advisory vote on named executive officer compensation passed (8,531,715 for, 103,135 against).
- 2021 Equity Incentive Plan approved by stockholders (7,451,194 for, 1,211,189 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828021020321/0001628280-21-020321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828021020321/csbr-20211020.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-020321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer